Cargando…

Role of novel type I interferon epsilon in mucosal immunity

Detalles Bibliográficos
Autores principales:	Xi, Y, Day, SL, Jackson, RJ, Ranasinghe, C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441604/ http://dx.doi.org/10.1186/1742-4690-9-S2-P192

Ejemplares similares

Role of novel type I interferon epsilon in viral infection and mucosal immunity
por: Xi, Yang, et al.
Publicado: (2012)

Intravaginal immunization using a novel antigen delivery device elicits robust vaccine antigen-specific systemic and mucosal humoral immune responses
por: McKay, PF, et al.
Publicado: (2012)

Prevalence of a type-I interferon immune response against malaria liver stage infection
por: Liehl, Peter, et al.
Publicado: (2010)

Mucosal prime with a replicating vaccinia-based vaccine promotes mucosal immunity against SIV
por: Tang, X, et al.
Publicado: (2012)

Identification of type I interferonopathies using blood interferon signature: the experience of a pediatric rheumatology center
por: Volpi, S, et al.
Publicado: (2015)

Immunization strategies to elicit mucosal immune response of HIV
por: Shi, Yinghui
Publicado: (2006)

Suppression of type I interferon production by human T-cell leukemia virus type 1 oncoprotein Tax
por: Jin, Dong-Yan, et al.
Publicado: (2014)

Unraveling the Convoluted Biological Roles of Type I Interferons in Infection and Immunity: A Way Forward for Therapeutics and Vaccine Design
por: Wijesundara, Danushka Kumara, et al.
Publicado: (2014)

P19-50 LB. Role of vaccine-induced innate and adaptive immunity in controlling mucosal transmission of SIV in macaques
por: Sui, Y, et al.
Publicado: (2009)

Characterization of the barrier conferred by type I interferon on the early steps of HIV-1 infection in primary cells
por: Goujon, Caroline, et al.
Publicado: (2011)

P01-04. Investigation of the sensitivity of acute-phase HIV-1 isolates to type I interferons
por: Dibben, O, et al.
Publicado: (2009)

The regulation of antiviral activity of interferon epsilon
por: Zhao, Fu-Rong, et al.
Publicado: (2022)

Defining a role for Interferon Epsilon in normal and complicated pregnancies
por: Miller, Derek, et al.
Publicado: (2022)

P11-15. Induction of a mucosal immune response to HIV after systemic immunization with poly(lactic acid) nanoparticles formulated with gag antigen and polyI:C
por: Primard, C, et al.
Publicado: (2009)

P19-46. Co-delivery of mucosal chemokine plasmids in a systemically delivered DNA vaccine elicits systemic and mucosal immune responses in mice and macaques
por: Kraynyak, KA, et al.
Publicado: (2009)

Protective role of interferon gamma in murine antigen-induced arthritis
por: Hückel, M, et al.
Publicado: (2004)

P19-35. Replicating adenovirus type 5 host range recombinant vaccine biodistribution in rhesus macaques following multiple mucosal routes of immunization
por: Patterson, J, et al.
Publicado: (2009)

Post-operative immune suppression is reversible with interferon gamma and independent of IL-6 pathways
por: Longbottom, ER, et al.
Publicado: (2015)

Alternate antigen processing in the presence of gamma interferon may misdirect the immune recognition of cancer
por: Woods, Katherine, et al.
Publicado: (2015)

131. The Protective Role of Mucosal Interferons in Infants with Respiratory Syncytial Virus (RSV) Infection
por: Taveras, Jeanette, et al.
Publicado: (2020)

Novel AIDS vaccine approach using epithelial stem cells as mucosal antigen-presenting cells
por: Bonello, G, et al.
Publicado: (2012)

Activation of interferon signaling pathway in primary effusion lymphoma cells by inhibition of viral interferon regulatory factor 1 of Kaposi's sarcoma-associated herpesvirus
por: Zhang, Y, et al.
Publicado: (2009)

Altered gastrointestinal mucosal permeability in asthma
por: Walker, John, et al.
Publicado: (2010)

P11-09. Mucosal vaccination with a transferrin-gp140 conjugate via the nasal but not vaginal route elicits robust systemic and vaginal IgG and IgA responses
por: Mann, JF, et al.
Publicado: (2009)

P11-04. PEGylated poly [2-(N,N-dimethylamino) ethyl methacrylate] as mucosal DNA delivery vector improves HIV-1-specific immune responses
por: Qiao, Y, et al.
Publicado: (2009)

Induction of HIV mucosal immunity at distal sites after encapsulation of NOD1 and NOD2 ligands in biodegradable nanocarriers
por: Pavot, V, et al.
Publicado: (2012)

PD-L1 and MHC-I expression in 19 human tumor cell lines and modulation by interferon-gamma treatment
por: Grenga, Italia, et al.
Publicado: (2014)

STING contributes to anti-glioma immunity via triggering type-I IFN signals in the tumor microenvironment
por: Ohkuri, Takayuki, et al.
Publicado: (2014)

P19-55 LB. Effective control of a pathogenic SIVmac239 challenge by a novel heterologous mucosal prime and intramuscular boost vaccine strategy
por: Chen, Z, et al.
Publicado: (2009)

Investigating the role of Wnt signalling in lobuloalveolar development of the mammary gland
por: Evans, RJ, et al.
Publicado: (2006)

Worst Oxygenation Index during the first 24 hours of ventilation predicts mortality
por: Jackson, RJ, et al.
Publicado: (2012)

Measurement of $\epsilon'/\epsilon$
por: Lubrano, Pasquale
Publicado: (1999)

Amyloid-β drives a type-1 interferon mediated neuro-inflammatory response in Alzheimer’s disease
por: Minter, Myles, et al.
Publicado: (2013)

TLR7/9 antagonist reduces HIV-1-induced immune activation
por: Chang, J, et al.
Publicado: (2012)

OLF1/EBF-associated zinc finger protein gene: a novel lupus susceptibility locus on chromosome 16q identified in a Chinese cohort
por: Shen, N, et al.
Publicado: (2003)

P19-47. Novel adenovirus type 5 vaccine platform induces cellular immunity against HIV-1 Gag, Pol, Nef despite the presence of Ad5 immunity
por: Gabitzsch, ES, et al.
Publicado: (2009)

Evaluation of immune response profiles of individuals with chronic Hepatitis C treated with interferon alpha and ribavirin, in the foundation of tropical medicine of Amazonas
por: Araújo, Ana Ruth, et al.
Publicado: (2010)

IL-12 plus CTB in intranasal DNA-MVA schemes improved magnitude and quality of both systemic and mucosal HIV cellular immune responses
por: Rodriguez, AM, et al.
Publicado: (2012)

P14-08. Intramuscular DNA delivery by electroporation leads to greatly enhanced systemic and mucosal immune responses and control of SIVmac251 challenge
por: Pavlakis, GN, et al.
Publicado: (2009)

Gluino penguins and epsilon'/epsilon
por: Gérard, J M, et al.
Publicado: (1984)

Cannot write session to /tmp/vufind_sessions/sess_9o839mv3s5u4oslbon3q10cdlk